The Food and Drug Administration has licensed the first freeze-dried plasma product for use in the United States, a change aimed squarely at the places where conventional frozen plasma is hardest to deliver: ambulances, rural hospitals, disaster zones and battlefields.
The FDA announced the licensure of Ezplaz Freeze-Dried Plasma at the end of July, granting the biologics license to Vascular Solutions, a subsidiary of Teleflex.
